Invariant Vα14 NKT lymphocytes: A double-edged immuno-regulatory T cell population

European Cytokine Network

Volumn 14, Issue 1, 2003, Pages 4-14

  Lisbonne, Mariette ^a   Leite De Moraes, Maria C ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CD4 ANTIGEN; CD5 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCOLIPID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 7; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALITIS; AUTOIMMUNITY; BACTERIAL INFECTION; CELL ACTIVITY; CELL MATURATION; CELL SUBPOPULATION; CELL TYPE; HEPATITIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; NONHUMAN; PARASITOSIS; REVIEW; SPLEEN; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; THYMOCYTE; TUMOR REJECTION;

BACTERIA (MICROORGANISMS);

EID: 0037505289     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Fowlkes BJ, Kruisbeek AM, Ton-That H, Weston MA, Coligan JE, Schwartz RH, Pardoll DM. 1987. A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family. Nature 329: 251.
2. Budd RC, Miescher GC, Howe RC, Lees RK, Bron C, MacDonald HR. 1987. Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes. J. Exp. Med. 166: 577.
3. - thymocytes contain an NK1.1 +, CD3 +, CD5hi, CD44hi, TCR-Vβ8+ subset. J. Immunol. 145: 1039.
4. - single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family. Proc. Natl. Acad. Sci. USA. 89: 6506.
5. - thymocytes with specific lymphokine secretion. Eur. J. Immunol. 23: 307.
6. Yoshimoto T, Paul W. 1994. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179: 1285.
7. - TCRαβ+ T cells are a potential source of IL-4 during primary immune response. J. Immunol. .155: 4544
8. - murine thymocytes positively selected by class I molecules. J. Exp. Med. 180: 653.
9. Makino Y, Kanno R, Ito T, Higashino K, Taniguchi M. 1995. Predominant expression of invariant Vα14+ TCR alpha chain in NK1.1 + T cell populations. Int. Immunol. 7: 1157.
10. Koseki H, Imai K, Nakayama F, Sado T, Moriwaki K, Taniguchi M. 1990. Homogenous junctional sequence of the V14 + T-cell antigen receptor alpha chain expanded in unprimed mice. Proc. Natl. Acad. Sci. USA 87: 5248.
11. - T cells in mice and humans. J. Exp. Med. 180: 1097.
12. Gombert JM, Herbelin A, Tancrede-Bohin E, Dy M, Carnaud C, Bach JF. 1996. Early quantitative and functional deficiency of NK1 + -like thymocytes in the NOD mouse. Eur. J. Immunol. 26: 2989.
13. Hammond KJ, Pellicci DG, Poulton LD, Naidenko OV, Scalzo AA, Baxter AG, Godfrey DI. 2001. CD1d-restricted NKT cells: an interstrain comparison. J. Immunol. 167: 1164.
14. Couedel C, Peyrat MA, Brossay L, Koezuka Y, Porcelli SA, Davodeau F, Bonneville M. 1998. Diverse CD1d-restricted reactivity patterns of human T cells bearing "invariant" AV24BV11 TCR. Eur. J. Immunol. 28: 4391.
15. Kent SC, Hafler DA, Strominger JL, Wilson SB. 1999. Noncanonical Valpha24JalphaQ T cells with conservative alpha chain CDR3 region amino acid substitutions are restricted by CD1d. Hum. Immunol. 60: 1080.
16. Bendelac A. 1995. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182: 2091.
17. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, Brutkiewicz RR. 1995. CD1 recognition by mouse NK1+ T lymphocytes. Science 268: 863.
18. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, VanKaer L. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6: 469.
19. Chen YH, Chiu NM, Mandal M, Wang N, Wang CR. 1997. Impaired NK1+ T cell development and early IL-4 production in CD1- deficient mice. Immunity 6: 459.
20. Chiu YH, Jayawardena J, Weiss A, Lee D, Park SH, Dautry-Varsat A, Bendelac A. 1999. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189: 103.
21. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M. 1997. CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science 278: 1626.
22. Burdin N, Brossay L, Koezuka Y, Smiley ST, Grusby MJ, Gui M, Taniguchi M, Hayakawa K, Kronenberg M. 1998. Selective ability of mouse CD1 to present glycolipids: alpha- galactosylceramide specifically stimulates V alpha 14 + NKT lymphocytes. J. Immunol. 161: 3271.
23. Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, Koezuka Y, Kronenberg M. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192: 741.
24. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191: 1895.
25. Gumperz JE, Miyake S, Yamamura T, Brenner MB. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195: 625.
26. Zeng D, Gazit G, Dejbakhsh-Jones S, Balk SP, Snapper S, Taniguchi M, Strober S. 1999. Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus. J. Immunol. 163: 5338.
27. Eberl G, Lees R, Smiley ST, Taniguchi M, Grusby MJ, MacDonald HR. 1999. Tissue-specific segregation of CD1d-dependent and CD1d-independent NKT cells. J. Immunol. 162: 6410.
28. Hammond KJ, Pelikan SB, Crowe NY, Randle-Barrett E, Nakayama T, Taniguchi M, Smyth MJ, van Driel IR, Scollay R, Baxter AG, Godfrey DI. 1999. NKT cells are phenotypically and functionally diverse. Eur J. Immunol. 29: 3768.
29. Baron JL, Gardiner L, Nishimura S, Shinkai K, Locksley R, Ganem D. 2002. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16: 583.
30. - NKT cells with distinct TCR alpha beta repertoires and differential distribution in lymphoid tissues. J. Immunol. 165: 2481.
31. Exley MA, He Q, Cheng O, Wang RJ, Cheney CP, Balk SP, Koziel MJ. 2002. Cutting edge: Compartmentalization of Th1-like noninvariant CD1d- reactive T cells in hepatitis C virus-infected liver. J. Immunol. 168: 1519.
32. Baker J, Verneris MR, Ito M, Shizuru JA, Negrin RS. 2001. Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. Blood 97: 2923.
33. + T cells. J. Immunol. 164: 2009.
34. + T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. J. Immunol. 165: 3673.
35. Ishihara S, Nieda M, Kitayama J, Osada T, Yabe T, Ishikawa Y, Nagawa H, Muto T Juji T. 1999. CD8(+)NKR-P1A (+)T cells preferentially accumulate in human liver. Eur. J. Immunol. 29: 2406.
36. Shimamura M, Huang YY, Suda Y, Kusumoto S, Sato K, Grusby MJ, Sato H, Nakayama T, Taniguchi M. 1999. Positive selection of NKT cells by CD1(+), CD11c(+) non-lymphoid cells residing in the extrathymic organs. Eur. J. Immunol. 29: 3962.
37. Tilloy F, Di Santo JP, Bendelac A, Lantz O. 1999. Thymic dependence of invariant V alpha 14+ natural killer-T cell development. Eur. J. Immunol. 29: 3313.
38. Gapin L, Matsuda JL, Surh CD, Kronenberg M. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2: 971.
39. Pellicci DG, Hammond KJ, Uldrich AP, Baxter AG, Smyth MJ, Godfrey DI. 2002. A natural killer T (NKT) cell developmental pathway involving a thymus- dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J. Exp. Med. 195: 835.
40. Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A. 2002. A thymic precursor to the NKT cell lineage. Science 296: 553.
41. + cells. J. Immunol. 164: 2412.
42. Eberl G, Lowin-Kropf B, MacDonald HR. 1999. Cutting edge: NKT cell development is selectively impaired in Fyn- deficient mice. J. Immunol. 163: 4091.
43. Walunas T, Wang B, Wang CR, Leiden JM. 2000. Cutting edge: the Ets1 transcription factor is required for the development of NKT cells in mice. J. Immunol. 164: 2857.
44. Nieuwenhuis EE, Neurath MF, Corazza N, Iijima H, Trgovcich J, Wirtz S, Glickman J, Bailey D, Yoshida M, Galle PR, Kronenberg M, Birkenbach M, Blumberg RS. 2002. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc. Natl. Acad. Sci. USA 99: 16951.
45. Vicari AP, Herbelin A, Leite-de-Moraes MC, Von Freeden-Jeffry U, Murray R, Zlotnik A. 1996. NK1.1+ T cells from IL-7-deficient mice have a normal distribution and selection but exhibit impaired cytokine production. Int. Immunol. 8: 1759.
46. Matsuda JL, Gapin L, Sidobre S, Kieper WC, Tan JT, Ceredig R, Surh CD, Kronenberg M. 2002. Homeostasis of V alpha 14i NKT cells. Nat. Immunol. 3: 966.
47. Sato H, Nakayama T, Tanaka Y, Yamashita M, Shibata Y, Kondo E, Saito Y, Taniguchi M. 1999. Induction of differentiation of pre-NKT cells to mature Valpha14 NKT cells by granulocyte/macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 96: 7439.
48. Ohteki T, Yoshida H, Matsuyama T, Duncan GS, Mak TW, Ohashi PS. 1998. The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells. J. Exp. Med. 187: 967.
49. Elewaut D, Brossay L, Santee SM, Naidenko OV, Burdin N, De Winter H, Matsuda J, Ware C, Cheroutre H, Kronenberg M. 2000. Membrane lymphotoxin is required for the development of different subpopulations of NKT cells. J. Immunol. 165: 671.
50. Honey K, Benlagha K, Beers C, Forbush K, Teyton L, Kleijmeer MJ, Rudensky AY, Bendelac A. 2002. Thymocyte expression of cathepsin L is essential for NKT cell development. Nat. Immunol. 3: 1069.
51. Singh N, Hong S, Scherer DC, Serizawa I, Burdin N, Kronenberg M, Koezuka Y, Van Kaer L. 1999. Cutting edge: activation of NKT cells by CD1d and alpha- galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163: 2373.
52. Leite-de-Moraes MC, Hameg A, Pacilio M, Koezuka Y, Taniguchi M, Van Kaer L, Schneider E, Dy M, Herbelin A. 2001. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J. Immunol. 166: 945.
53. Leite-de-Moraes MC, Lisbonne M, Arnould A, Machavoine F, Herbelin A, Dy M, Schneider E. 2002. Ligand-activated natural killer T lymphocytes promptly produce IL-3 and GM-CSF in vivo: relevance to peripheral myeloid recruitment. Eur. J. Immunol. 32: 1897.
54. Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-de-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A. 2001. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 7: 1057.
55. Kitamura H, Ohta A, Sekimoto M, Sato M, Iwakabe K, Nakui M, Yahata T, Meng H, Koda T, Nishimura S, Kawano T, Taniguchi M, Nishimura T. 2000. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell. Immunol. 199: 37.
56. Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, Ohmi Y, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nishimura T. 1999. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)- 12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189: 1121.
57. Carnaud C, Lee D, Donnars O, Park SH, Beavis A, Koezuka Y, Bendelac A. 1999. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163: 4647.
58. Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, Takeda K, Yagita H, Godfrey DI. 2002. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 99: 1259.
59. Lisbonne M, Tonanny MB, Fourneau JM, Kronenberg M, Endert PV, Dy M, Herbelin A, Schneider E, Leite-de-Moraes MC. In vivo activation of Natural Killer T cells by α-GalCer sequentially induces Fas-dependent and -independent cytotoxicity. Submitted.
60. Lisbonne M, Diem S, Castro-Keller A, Lefort J, Araujo LM, Fourneau JM, Kronenberg M, Taniguchi M, Van-Endert P, Dy M, Russo M, Vargaftig B, Herbelin A, Leite-de-Moraes MC. The Th2 response in allergen-induced airway inflammation and hyperreactivity is mediated by invariant V α 14 NKT cells. Submitted.
61. Spada FM, Borriello F, Sugita M, Watts GF, Koezuka Y, Porcelli SA. 2000. Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur. J. Immunol. 30: 3468.
62. Fujii S, Shimizu K, Kronenberg M, Steinman RM. 2002. Prolonged IFN-gamma-producing NKT response induced with alpha- galactosylceramide-loaded DCs. Nat. Immunol. 3: 867.
63. Naumov YN, Bahjat KS, Gausling R, Abraham R, Exley MA, Koezuka Y, Balk SB, Strominger JL, Clare-Salzer M, Wilson SB. 2001. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 98: 13838.
64. -TCR alpha beta+ thymocytes. Int. Immunol. 9: 73.
65. Leite-de-Moraes MC, Moreau G, Arnould A, Machavoine F, Garcia C, Papiernik M, Dy M. 1998. IL-4-producing NKT cells are biased towards IFN-gamma production by IL- 12. Influence of the microenvironment on the functional capacities of NKT cells. Eur. J. Immunol. 28: 1507.
66. Leite-de-Moraes MC, Hameg A, Arnould A, Machavoine F, Koezuka Y, Schneider E, Herbelin A, Dy M. 1999. A distinct IL-18-induced pathway to fully activate NKT lymphocytes independently from TCR engagement. J. Imnumol. 163: 5871.
67. Hameg A, Apostolou I, Leite-de-Moraes MC, Gombert JM, Garcia C, Koezuka Y, Bach JF, Herbelin A. 2000. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules and auto-presents the α-galactosylceramide antigen. J. Immunol. 165: 4917.
68. Lee PT, Benlagha K, Teyton L, Bendelac A. 2002. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195: 637.
69. Kita H, Naidenko OV, Kronenberg M, Ansari AA., Rogers P, He XS, Koning F, Mikayama T, Van De Water J, Coppel RL, Kaplan M, Gershwin ME. 2002. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 123: 1031.
70. Miyamoto K, Miyake S, Yamamura T. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413: 531.
71. Hayakawa Y, Takeda K, Yagita H, Kakuta S, Iwakura Y, Van Kaer L, Saiki I, Okumura K. 2001. Critical contribution of IFN-gamma and NK cells, but not perforin- mediated cytotoxicity, to antimetastatic effect of alpha- galactosylceramide. Eur. J. Immunol. 31: 1720.
72. Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F, Nakayama T, Taniguchi M. 2000. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191: 105.
73. Leite-de-Moraes MC, Herbelin A, Gouarin C, Koezuka Y, Schneider E, Dy M. 2000. Fas/Fas ligand interactions promote activation-induced cell death of NKT lymphocytes. J. Immunol. 165: 4367.
74. Sonoda KH, Exley M, Snapper S, Balk SP, Stein-Streilein J. 1999. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190: 1215.
75. Sonoda KH, Faunce DE, Taniguchi M, Exley M, Balk S, Stein-Streilein J. 2001. NKT cell-derived IL-10 is essential for the differentiation of antigen- specific T regulatory cells in systemic tolerance. J. Immunol. 166: 42.
76. Sonoda KH, Stein-Streilein J. 2002. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur. J. Immunol. 32: 848.
77. Faunce DE, Sonoda KH, Stein-Streilein J. 2001. MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol. 166: 313.
78. + T cells to the spleen during the generation of regulatory T cells in tolerance. J. Immunol. 169: 31.
79. Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, Bendelac A, Bach JF, Monteiro RC. 1998. Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188: 1831.
80. Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K. 2001. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166: 6012.
81. Burdin N, Brossay L, Kronenberg M. 1999. Immunization with α-galactosylceramide polarizes CD1-reactive NKT cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29: 2014.
82. Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, Kronenberg M, Koezuka Y, Van Kaer L. 2001. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7: 1052.
83. Askenase PW. 2001. Yes T cells, but three different T cells (αβ, γδ and NK, T cells), and also B-1 cells mediate contact sensitivity (Review). Clin. Exp. Immunol. 125: 345.
84. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W. 2002. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17: 629.
85. Wilson SB, Kent SC, Horton HF, Hill AA, Bollyky PL, Hafler DA, Strominger JL, Byrne MC. 2000. Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes. Proc. Natl. Acad. Sci. USA 97: 7411.
86. Lee PT, Putnam A, Benlagha K, Teyton L, Gottlieb PA, Bendelac A. 2002. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 110: 793.
87. Karadimitris A, Gadola S, Altamirano M, Brown D, Woolfson A, Klenerman P, Chen JL, Koezuka Y, Roberts IA, Price DA, Dusheiko G, Milstein C, Fersht A, Luzzatto L, Cerundolo V. 2001. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc. Natl. Acad. Sci. USA 98: 3294.
88. Poulton LD, Smyth MJ, Hawke CG, Silveira P, Shepherd D, Naidenko OV, Godfrey DI, Baxter AG. 2001. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 13: 887.
89. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187: 1047.
90. Shi FD, Flodstrom M, Balasa B, Kim SH, Van Gunst K, Strominger JL, Wilson SB, Sarvetnick N. 2001. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc. Natl. Acad. Sci. USA 98: 6777.
91. Wang B, Geng YB, Wang CR. 2001. CD1-restricted NKT cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194: 313.
92. Beaudoin L, Laloux V, Novak J, Lucas B, Lehuen A. 2002. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 17: 725.
93. +, NK1.1+ T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. USA 92: 11931.
94. Illes Z, Kondo T, Newcombe J, Oka N, Tabira T, Yamamura T. 2000. Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 164: 4375.
95. Singh AK, Wilson MT, Hong S, Olivares-Villagomez D, Du C, Stanic AK, Joyce S, Sriram S, Koezuka Y, Van Kaer L. 2001. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194: 1801.
96. Jahng AW, Maricic I, Pedersen B, Burdin N, Naidenko O, Kronenberg M, Koezuka Y, Kumar V. 2001. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194: 1789.
97. Dieli F, Sireci G, Russo D, Taniguchi M, Ivanyi J, Fernandez C, Troye-Blomberg M, De Leo G, Salerno A. 2000. Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J. Exp. Med. 192: 1645.
98. Apostolou I, Takahama Y, Belmant C, Kawano T, Huerre M, Marchal G, Cui J, Taniguchi M, Nakauchi H, Fournie JJ, Kourilsky P, Gachelin G. 1999. Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl. Acad. Sci. USA 96: 5141.
99. Ronet C, Mempel M, Kuse S, Ueno T, Gilleron M, Puzo G, Buzoni-Gatel D, Takahama Y, Gachelin G. Dominant role for CXCL10 in the migration of NKT cells to acute inflammatory lesions. submitted.
100. Behar SM, Dascher CC, Grusby MJ, Wang CR, Brenner MB. 1999. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189: 1973.
101. Chackerian A, Alt J, Perera V, Behar SM. 2002. Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 70: 6302.
102. Schofield L, McConville MJ, Hansen D, Campbell AS, Fraser-Reid B, Grusby MJ, Tachado SD. 1999. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283: 225.
103. Duthie MS, Wleklinski-Lee M, Smith S, Nakayama T, Taniguchi M, Kahn SJ. 2002. During Trypanosoma cruzi infection CD1d-restricted NKT cells limit parasitemia and augment the antibody response to a glycophosphoinositol- modified surface protein. Infect. Immun. 70: 36.
104. Molano A, Park SH, Chiu YH, Nosseir S, Bendelac A, Tsuji M. 2000. Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NKT cell activation and antimalarial responses. J. Immunol. 164: 5005.
105. Procopio DO, Almeida IC, Torrecilhas AC, Cardoso JE, Teyton L, Travassos LR, Bendelac A, Gazzinelli RT. 2002. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway. J. Immunol. 169: 3926.
106. - NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro. J. Immunol. 164: 1463.
107. Gonzalez-Aseguinolaza G, Van Kaer L, Bergmann CC, Wilson JM, Schmieg J, Kronenberg M, Nakayama T, Taniguchi M, Koezuka Y, Tsuji M. 2002. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 195: 617.
108. Gonzalez-Aseguinolaza G, de Oliveira C, Tomaska M, Hong S, Bruna-Romero O, Nakayama T, Taniguchi M, Bendelac A, Van Kaer L, Koezuka Y, Tsuji M. 2000. alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA 97: 8461.
109. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192: 921.
110. Exley MA, Bigley NJ, Cheng O, Tahir SM, Smiley ST, Carter QL, Stills HF, Grusby MJ, Koezuka Y, Taniguchi M, Balk SP. 2001. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J. Leukoc. Biol. 69: 713.
111. Grubor-Bauk B, Simmons A, Mayrhofer G, Speck PG. 2003. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. J. Immunol. 170: 1430.
112. Johnson TR, Hong S, Van Kaer L, Koezuka Y, Graham BS. 2002. NKT cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 76: 4294.
113. Motsinger A, Haas DW, Stanic AK, Van Kaer L, Joyce S, Unutmaz D. 2002. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J. Exp. Med. 195: 869.
114. Kim CH, Butcher EC, Johnston B. 2002. Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol. 23: 516.
115. Fleuridor R, Wilson B, Hou R, Landay A, Kessler H, Al-Harthi L. 2003. CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection. Immunology 108: 3.
116. van der Vliet HJ, von Blomberg BM, Hazenberg MD, Nishi N, Otto SA, van Benthem BH, Prins M, Claessen FA, van den Eertwegh AJ, Giaccone G, Miedema F, Scheper RJ, Pinedo HM. 2002. Selective decrease in circulating V alpha 24+ V beta 11+ NKT cells during HIV type 1 infection. J. Immunol. 168: 1490.
117. Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, Kaneko Y, Koseki H, Kanno M, Taniguchi M. 1997. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623.
118. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Sato H, Kondo E, Harada M, Koseki H, Nakayama T, Tanaka Y, Taniguchi M. 1998. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl. Acad. Sci. USA 95: 5690.
119. Toura I, Kawano T, Akutsu Y, Nakayama T, Ochiai T, Taniguchi M. 1999. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J. Immunol. 163: 2387.
120. Tomura M, Yu WG, Ahn HJ, Yamashita M, Yang YF, Ono S, Hamaoka T, Kawano T, Taniguchi M, Koezuka Y, Fujiwara H. 1999. A novel function of Valpha14+ CD+ NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 163: 93.
121. Yang YF, Tomura M, Ono S, Hamaoka T, Fujiwara H. 2000. Requirement for IFN-gamma in IL-12 production induced by collaboration between V(alpha)14(+) NKT cells and antigen-presenting cells. Int. Immunol. 12: 1669.
122. Hayakawa Y, Takeda K, Yagita H, Smyth MJ, Van Kaer L, Okumura K, Saiki I. 2002. IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T- cell ligand, alpha-galactosylceramide. Blood 100: 1728.
123. Crowe NY, Smyth MJ, Godfrey DI. 2002. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J. Exp. Med. 196: 119.